Biogaia AB ADR (BIOGY)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Biogaia AB ADR, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Biogaia AB ADR (BIOGY) has returned 0.00% so far this year and 13.12% over the past 12 months.

Based on dividend-adjusted daily data since Feb 19, 2020, BIOGY's average daily return is +0.01%, while the average monthly return is +0.44%. At this rate, your investment would double in approximately 13.2 years.

Historically, 37% of months were positive and 63% were negative. The best month was May 2024 with a return of +31.5%, while the worst month was May 2022 at -67.9%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 3 months.

On a daily basis, BIOGY closed higher 5% of trading days. The best single day was Mar 13, 2020 with a return of +29.8%, while the worst single day was May 27, 2022 at -43.4%.

Biogaia AB ADR has an annualized alpha of 0.42%, beta of 0.15, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since March 02, 2020.

• This stock participated in 76.76% of S&P 500 Index downside but only 4.76% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.15 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

BIOGY ranks 60 for risk / return — better than 60% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for Biogaia AB ADR (BIOGY) and compare them to a chosen benchmark (S&P 500 Index).

Biogaia AB ADR provided a 6.38% dividend yield over the last twelve months, with an annual payout of $0.70 per share. The company has been increasing its dividends for 2 consecutive years.

The table displays the monthly dividend distributions for Biogaia AB ADR. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Biogaia AB ADR. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Biogaia AB ADR was 76.56%, occurring on Sep 9, 2022. The portfolio has not yet recovered.

The current Biogaia AB ADR drawdown is 59.75%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Biogaia AB ADR over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Biogaia AB ADR is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.